Cargando…
Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
Hypertension is a major, if not the most important, contributor to the disease burden and premature death globally which is largely related to cardiovascular disease. In both the primary and the secondary preventions of cardiovascular disease, blood pressure (BP) targets are often not achieved which...
Autores principales: | Lafeber, M., Spiering, W., Visseren, F. L. J., Grobbee, D. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833798/ https://www.ncbi.nlm.nih.gov/pubmed/27083928 http://dx.doi.org/10.1007/s11906-016-0648-3 |
Ejemplares similares
-
Excess Cardiovascular Risk in Diabetic Women: A Case for Intensive Treatment
por: Recarti, C., et al.
Publicado: (2015) -
The feasibility of polypill for cardiovascular disease prevention in Asian Population
por: Sukonthasarn, Apichard, et al.
Publicado: (2020) -
Novel Medical Treatments for Hypertension and Related Comorbidities
por: Davis, Jared, et al.
Publicado: (2018) -
New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?
por: Paulis, Ludovit, et al.
Publicado: (2015) -
Disaster hypertension and cardiovascular events in disaster and COVID‐19 pandemic
por: Narita, Keisuke, et al.
Publicado: (2021)